Isatuximab for the treatment of monoclonal gammopathy of renal significance (MGRS): Results from a prospective multicenter Phase 2 trial
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Divaya Bhutani, Rajshekhar Chakraborty, Michael Hughes, Suzanne Lentzsch, Samuel Pan, Shayan Shirazayan, Sherley Mejia, Naomi Sender, Elizabeth Shelton, Meghan Sise
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108447437